25 May 2013
Keywords: cognex, approved, sweden, cleared, warner-lambert, alzheimer, drug
Article | 06 March 1995
- Sweden has cleared Warner-Lambert's Alzheimer's drug Cognex (tacrine) for marketing. Marketing applications are currently pending in Belgium, Denmark, Germany, Greece, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.